Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques
Launched by TAIPEI CITY HOSPITAL · May 10, 2014
Trial Information
Current as of September 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Angulated bifurcation:MV(main branch) and SB(side branch) angle\>70 degree. MV diameter≥2.5mm and eligible for stenting. lesion stenotic severity\>70% by QCA(Quantitative coronary analysis). 1 stent strategy. SYNTAX\>22 Procedure success. de novo lesion
- Exclusion Criteria:
- • Bifurcation lesions intervention without side br. ballooning after stents deployment or procedure incomplete. Left main coronary artery bifurcational lesions. Elective,provisional or bail-out stenting for side br.
About Taipei City Hospital
Taipei City Hospital is a leading healthcare institution in Taiwan dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital is committed to conducting rigorous, ethically sound research that adheres to the highest standards of scientific integrity. Leveraging a multidisciplinary team of experienced clinicians and researchers, Taipei City Hospital focuses on a wide range of therapeutic areas, aiming to enhance treatment options and outcomes for diverse patient populations. Through collaboration with academic institutions and industry partners, the hospital fosters an environment of continuous learning and discovery, contributing to the global advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials